Can treatment adverse events be optimized by switching between different sphingosine 1-phosphate receptor modulators in multiple sclerosis? A case series

Simone Guerrieri; Martina Rubin; Irene Gattuso; Chiara Zanetta; Angela Genchi; Paolo Preziosa; Maria Assunta Rocca; Massimo Filippi; Lucia Moiola

doi:10.1007/s00415-024-12342-z

Can treatment adverse events be optimized by switching between different sphingosine 1-phosphate receptor modulators in multiple sclerosis? A case series

J Neurol. 2024 Jun;271(6):3678-3681. doi: 10.1007/s00415-024-12342-z. Epub 2024 Apr 2.

Authors

Simone Guerrieri¹, Martina Rubin^{1

2

3}, Irene Gattuso^{1

3}, Chiara Zanetta¹, Angela Genchi^{1

3}, Paolo Preziosa^{1

2

3}, Maria Assunta Rocca^{1

2

3}, Massimo Filippi^{4

5

6

7

8}, Lucia Moiola¹

Affiliations

¹ Multiple Sclerosis Center, Neurology Unit, IRCCS San Raffaele Scientific Institute, Via Olgettina, 60, 20132, Milan, Italy.
² Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
³ Vita-Salute San Raffaele University, Milan, Italy.
⁴ Multiple Sclerosis Center, Neurology Unit, IRCCS San Raffaele Scientific Institute, Via Olgettina, 60, 20132, Milan, Italy. filippi.massimo@hsr.it.
⁵ Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy. filippi.massimo@hsr.it.
⁶ Vita-Salute San Raffaele University, Milan, Italy. filippi.massimo@hsr.it.
⁷ Neurorehabilitation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy. filippi.massimo@hsr.it.
⁸ Neurophysiology Service, IRCCS San Raffaele Scientific Institute, Milan, Italy. filippi.massimo@hsr.it.

PMID: 38564055
DOI: 10.1007/s00415-024-12342-z

No abstract available

Publication types

Letter
Case Reports

MeSH terms

Adult
Female
Fingolimod Hydrochloride / adverse effects
Fingolimod Hydrochloride / therapeutic use
Humans
Male
Middle Aged
Multiple Sclerosis* / drug therapy
Multiple Sclerosis, Relapsing-Remitting / drug therapy
Sphingosine 1 Phosphate Receptor Modulators* / pharmacology

Substances

Sphingosine 1 Phosphate Receptor Modulators
Fingolimod Hydrochloride